Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04550494
Title Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

ovarian cancer

prostate cancer

breast cancer

stomach cancer

pancreatic cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST